Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Four Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries Lawsuit indicates the BioZorb markers failed to properly absorb into the women’s bodies, leading to infections and other serious complications. May 5, 2025 Irvin Jackson Add Your Comments Hologic, Inc. faces a multi-plaintiff lawsuit brought by a group of four women who received the company’s BioZorb tissue marker during breast cancer treatments, and each experienced complications that later required surgical removal of the implant, and reignited fears about a possible cancer recurrence. The complaint (PDF) was filed by Diane Wheatley, Penny Armstrong, Donna Bolden and Tiffany Haines in the U.S. District Court for the District of Massachusetts on April 30, alleging the the BioZorb breast tissue marker was defective and unreasonably dangerous as originally designed and sold in recent years. Their lawsuit joins more than 100 other federal BioZorb lawsuits brought by women throughout the U.S., each raising similar allegations that the marker failed to dissolve once it was implanted, resulting in severe pain, infections, rashes, migration, erosion and other complications. BioZorb Complications Experienced by Women Nationwide The BioZorb Marker is a small implant approved for use among breast cancer survivors and other individuals who require targeted radiation therapy. It consists of a biodegradable spacer made from polylactic acid, and six permanent clips. While the BioZorb Marker is supposed to gradually dissolve into the body, leaving only the titanium clips behind to aid in the precise marking of previously removed tumor sites, breast cancer survivors report experiencing severe pain, discomfort and other BioZorb marker injuries after the device failed to absorb. As a result of these complications, the U.S. Food and Drug Administration (FDA) announced a BioZorb recall in October 2024, removing all of the breast tissue markers from the market after the manufacturer acknowledged that there was a higher-than-expected rate of problems, including incidents where the marker failed, resulting in the need for surgical removal of the device. BioZorb Implant Lawsuit Did you or a loved one suffer injuries from a BioZorb Marker? Lawyers are reviewing claims for individuals who received a BioZorb implant and suffered injuries. Learn More SEE IF YOU QUALIFY FOR COMPENSATION BioZorb Implant Lawsuit Did you or a loved one suffer injuries from a BioZorb Marker? Lawyers are reviewing claims for individuals who received a BioZorb implant and suffered injuries. Learn More SEE IF YOU QUALIFY FOR COMPENSATION This recent multi-plaintiff complaint outlines complications experienced by four unrelated women, each indicating that they received a BioZorb tissue marker implant and subsequently experienced serious side effects. Wheatley, from Pennsylvania, was implanted with a BioZorb during a right breast lumpectomy in May 2023. The lawsuit indicates the BioZorb failed to absorb, resulting in deformity, pain, scarring, swelling, infection, seroma and rash. She had the implant removed in January, but fears it may lead to the return of her cancer. Armstrong, a Michigan resident, says she received a BioZorb implant during breast cancer surgery in October 2017 and later suffered sharp stabbing pain, deformity, scarring and infection. The device was surgically removed in September 2018 after it failed to absorb as intended, according to the complaint. During a June 2021 lumpectomy, Bolden, of Oregon, received a BioZorb implant that later caused infection, pain and other complications. The device remains in place and has not yet been removed. Haines, a Tennessee resident, was implanted with a BioZorb in October 2021, just months after Bolden, and experienced similar issues. She continues to fear the possible return of her tumor and associated cancer. The women say Hologic knew or should have known about the risks and the device’s frequent failure to absorb, but failed to pass on those concerns to patients or the medical community. “Hologic was aware of Medical Device Reports (“MDRs”) that reported patient complications including, but not limited to, infection, fluid buildup, device migration, device erosion, pain, discomfort, rash, extended resorption time of the device, and additional surgeries,” the lawsuit states. “Hologic also knew or should have known of clinical evidence that shows that BioZorb can cause a hard, palpable lump, causing patient pain and discomfort.” Instead, the lawsuit claims the company willfully endangered cancer patients’ health in order to maximize profits. The women present claims of design defect, failure to warn, manufacturing defect, negligence, and breach of implied warranty of merchantability. May 2025 BioZorb lawsuits Update Currently, all BioZorb lawsuits have been filed in the U.S. District Court for the District of Massachusetts, where Hologic’s headquarters are located. Given similar allegations and claims raised in the complaints, the litigation has been consolidated before U.S. District Judge Allison D. Burroughs, who is presiding over coordinated discovery and preparing a small group of cases for early trial dates. In July 2024, the Court ordered the parties to select a group of 10 BioZorb lawsuits for a “bellwether” process, with each side designating five cases for a Discovery Pool. Those BioZorb injury cases have been going through depositions, exchange of medical records and other case-specific discovery, to help the parties gather information to select a smaller group of cases to present to juries as early test cases. In December 2024, the parties whittled that list down to four bellwether trial candidates, and in January 2025, Judge Burroughs announced that the first BioZorb lawsuit bellwether trial will begin on September 8, 2025. While the outcome of these early trial dates will not have any impact on other claims being pursued against the manufacturer, the average BioZorb lawsuit payouts awarded by juries are likely to have a substantial impact on settlement negotiations needed to avoid each claim ultimately being set for trial in the future. Tags: BioZorb, BioZorb Recall, Breast Cancer, Hologic, Infection Find Out If You Qualify for BioZorb Failure Compensation More BioZorb Stories Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries July 7, 2025 BioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve June 30, 2025 Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection June 4, 2025 1 Comments Bettye May 9, 2025 Don’t let nobody put this in you, It doesn’t do what they say it do Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Bard PowerPort Infection Lawsuit Chosen for First Bellwether Trial in Feb. 2026 (Posted: today) A federal judge has selected a Bard PowerPort infection lawsuit to serve as the first in a series of bellwether trials over claims the port catheters were defectively designed. MORE ABOUT: BARD POWERPORT LAWSUITCook Medical Angiographic Catheter Recall Issued Following Multiple Reports of Serious Injury: FDA (06/27/2025)More Than 1,700 Bard PowerPort Lawsuits Now Filed in State and Federal Courts (06/03/2025)6 Bard PowerPort Lawsuits Selected for Bellwether Trials in Federal MDL (05/19/2025) Status of Hair Dye Bladder Cancer Lawsuits Outlined for Court (Posted: yesterday) One hair dye bladder cancer lawsuit out of at least 15 filed to date has been chosen as the lead case against several cosmetics manufacturers. MORE ABOUT: HAIR DYE LAWSUIT12 Hair Dye Lawsuits Over Bladder Cancer Risks Assigned to One Judge in California State Court (07/01/2025)Judge To Meet With Hair Dye Lawyers in Bladder Cancer Lawsuit for Initial Status Conference (06/16/2025)Lawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (05/09/2025) Social Media Addiction Lawsuit Set for Trial in California State Court in November 2025 (Posted: yesterday) A series of social media addiction lawsuit trials will begin this November in California state court, as federal bellwether cases are prepared for likely 2026 trial dates. MORE ABOUT: SOCIAL MEDIA ADDICTION LAWSUITSnapchat Lawsuit Claims Platform Unleashed Experimental AI on Children Without Safeguards (07/09/2025)Fortnite Settlement Provides $126M in Payouts to Players Targeted With Unwanted Items: FTC (07/01/2025)Video Game Addiction Can Begin as Early as Elementary School: Study (06/27/2025)
Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries July 7, 2025
BioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve June 30, 2025
Bard PowerPort Infection Lawsuit Chosen for First Bellwether Trial in Feb. 2026 (Posted: today) A federal judge has selected a Bard PowerPort infection lawsuit to serve as the first in a series of bellwether trials over claims the port catheters were defectively designed. MORE ABOUT: BARD POWERPORT LAWSUITCook Medical Angiographic Catheter Recall Issued Following Multiple Reports of Serious Injury: FDA (06/27/2025)More Than 1,700 Bard PowerPort Lawsuits Now Filed in State and Federal Courts (06/03/2025)6 Bard PowerPort Lawsuits Selected for Bellwether Trials in Federal MDL (05/19/2025)
Status of Hair Dye Bladder Cancer Lawsuits Outlined for Court (Posted: yesterday) One hair dye bladder cancer lawsuit out of at least 15 filed to date has been chosen as the lead case against several cosmetics manufacturers. MORE ABOUT: HAIR DYE LAWSUIT12 Hair Dye Lawsuits Over Bladder Cancer Risks Assigned to One Judge in California State Court (07/01/2025)Judge To Meet With Hair Dye Lawyers in Bladder Cancer Lawsuit for Initial Status Conference (06/16/2025)Lawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (05/09/2025)
Social Media Addiction Lawsuit Set for Trial in California State Court in November 2025 (Posted: yesterday) A series of social media addiction lawsuit trials will begin this November in California state court, as federal bellwether cases are prepared for likely 2026 trial dates. MORE ABOUT: SOCIAL MEDIA ADDICTION LAWSUITSnapchat Lawsuit Claims Platform Unleashed Experimental AI on Children Without Safeguards (07/09/2025)Fortnite Settlement Provides $126M in Payouts to Players Targeted With Unwanted Items: FTC (07/01/2025)Video Game Addiction Can Begin as Early as Elementary School: Study (06/27/2025)